Barclays’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-900
| Closed | -$119K | – | 7603 |
|
|
2018
Q4 | $119K | Sell |
900
-15,100
| -94% | -$1.93M | ﹤0.01% | 4927 |
|
|
2018
Q3 | $2.14M | Sell |
16,000
-371,500
| -96% | -$55.7M | ﹤0.01% | 2800 |
|
|
2018
Q2 | $61.7M | Buy |
387,500
+384,100
| +11,297% | +$57M | 0.05% | 308 |
|
|
2018
Q1 | $486K | Sell |
3,400
-3,100
| -48% | -$424K | ﹤0.01% | 4011 |
|
|
2017
Q4 | $865K | Sell |
6,500
-6,600
| -50% | -$843K | ﹤0.01% | 3254 |
|
|
2017
Q3 | $1.63M | Sell |
13,100
-7,800
| -37% | -$1.07M | ﹤0.01% | 2540 |
|
|
2017
Q2 | $2.94M | Sell |
20,900
-22,500
| -52% | -$2.81M | ﹤0.01% | 1905 |
|
|
2017
Q1 | $4.89M | Sell |
43,400
-139,200
| -76% | -$16.2M | 0.01% | 1343 |
|
|
2016
Q4 | $19.2M | Buy |
182,600
+167,900
| +1,142% | +$18M | 0.02% | 619 |
|
|
2016
Q3 | $1.85M | Sell |
14,700
-1,900
| -11% | -$242K | ﹤0.01% | 2064 |
|
|
2016
Q2 | $2.29M | Sell |
16,600
-7,700
| -32% | -$1.02M | ﹤0.01% | 1899 |
|
|
2016
Q1 | $3.35M | Sell |
24,300
-36,600
| -60% | -$5.02M | 0.01% | 1493 |
|
|
2015
Q4 | $9.74M | Buy |
60,900
+23,500
| +63% | +$3.63M | 0.01% | 901 |
|
|
2015
Q3 | $4.97M | Sell |
37,400
-10,100
| -21% | -$1.32M | 0.01% | 1376 |
|
|
2015
Q2 | $5.42M | Sell |
47,500
-5,200
| -10% | -$622K | 0.01% | 1432 |
|
|
2015
Q1 | $6.27M | Buy |
52,700
+5,500
| +12% | +$733K | 0.01% | 1394 |
|
|
2014
Q4 | $6.84M | Sell |
47,200
-23,800
| -34% | -$2.99M | 0.01% | 1448 |
|
|
2014
Q3 | $9.3M | Buy |
71,000
+26,000
| +58% | +$3.42M | 0.01% | 1229 |
|
|
2014
Q2 | $5.63M | Sell |
45,000
-382,100
| -89% | -$49.4M | 0.01% | 1634 |
|
|
2014
Q1 | $68.3M | Buy |
427,100
+406,700
| +1,994% | +$66.9M | 0.08% | 228 |
|
|
2013
Q4 | $2.73M | Sell |
20,400
-17,300
| -46% | -$2.22M | ﹤0.01% | 2355 |
|
|
2013
Q3 | $4.07M | Sell |
37,700
-22,900
| -38% | -$2.48M | ﹤0.01% | 1855 |
|
|
2013
Q2 | $5.13M | Buy |
+60,600
| New | +$5.42M | 0.01% | 1608 |
|
Barclays's ATHN Position: Q1 2019 in Review
Barclays sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 72,825 shares — an estimated $9.61M sold.
Barclays first reported a position in ATHN in Q2 2013 and held it in 23 quarters. The position peaked at $28.8M in Q1 2014. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- Barclays reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- Barclays sold 72,825 Athenahealth, Inc. shares in Q1 2019, an estimated $9.61M.
- Barclays first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 23 quarters.
- Barclays's Athenahealth, Inc. position peaked at $28.8M in Q1 2014.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.